HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jose A Enciso-Moreno Selected Research

Jose A Enciso-Moreno Research Topics

Disease

5Infections
01/2020 - 06/2014
4Tuberculosis (Tuberculoses)
01/2021 - 06/2014
4Ulcer
01/2020 - 01/2014
4Diabetic Foot
01/2020 - 01/2014
2Inflammation (Inflammations)
01/2021 - 01/2016
2Communicable Diseases (Infectious Diseases)
01/2017 - 04/2016
2Reinfection
01/2017 - 02/2016
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2021
1Muscle Cramp (Cramp)
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2020
1Hypoxia (Hypoxemia)
01/2018
1Latent Tuberculosis
01/2018
1Rheumatoid Arthritis
01/2017
1Foot Ulcer
01/2016
1Vascular Diseases (Vascular Disease)
01/2016
1Wounds and Injuries (Trauma)
01/2016
1Neoplasms (Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

4Antimicrobial Cationic PeptidesIBA
01/2021 - 12/2015
4Metformin (Glucophage)FDA LinkGeneric
01/2020 - 01/2016
2CathelicidinsIBA
01/2021 - 06/2014
2Ribonuclease 7IBA
01/2020 - 01/2018
2CytokinesIBA
01/2017 - 12/2015
2Antimicrobial PeptidesIBA
04/2016 - 06/2014
2Vitamin DFDA LinkGeneric
02/2016 - 01/2016
2Calcitriol (Calcijex)FDA LinkGeneric
01/2016 - 01/2014
1Messenger RNA (mRNA)IBA
01/2021
1Dehydroepiandrosterone (DHEA)IBA
01/2021
1DefensinsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2018
1innate defense regulating peptide 1018IBA
01/2018
1S100 Calcium Binding Protein A7IBA
01/2018
1Peptides (Polypeptides)IBA
01/2018
1Ribonucleases (Ribonuclease)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Secretory Phospholipases A2IBA
01/2018
1Immunologic Factors (Immunomodulators)IBA
01/2017
1beta-DefensinsIBA
01/2017
1AutoantibodiesIBA
01/2017
1Adenosine Monophosphate (AMP)IBA
01/2017
1Interferon Type IIBA
01/2017
1human neutrophil peptide 1IBA
04/2016
1Isoleucine (L-Isoleucine)FDA Link
02/2016
1Purinergic P2X7 ReceptorsIBA
12/2015
1Tuberculin (PPD)IBA
06/2014
1Proteins (Proteins, Gene)FDA Link
06/2014
1Interferon-gamma (Interferon, gamma)IBA
06/2014
1GoldIBA
06/2014

Therapy/Procedure

2Therapeutics
01/2021 - 02/2016